ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Boston Study Finds Adenocarcinoma Of Esophagus Increasing

July 14, 1989

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

National Breast Cancer Coalition Sets Goal To End Breast Cancer By Jan. 1, 2020

September 24, 2010